Artwork

Content provided by Esther C Kane CAPS, C.D.S., Esther C Kane CAPS, and C.D.S.. All podcast content including episodes, graphics, and podcast descriptions are uploaded and provided directly by Esther C Kane CAPS, C.D.S., Esther C Kane CAPS, and C.D.S. or their podcast platform partner. If you believe someone is using your copyrighted work without your permission, you can follow the process outlined here https://player.fm/legal.
Player FM - Podcast App
Go offline with the Player FM app!

Second-most commonly prescribed drug for older adults is linked to bone loss

12:22
 
Share
 

Manage episode 452244769 series 3609475
Content provided by Esther C Kane CAPS, C.D.S., Esther C Kane CAPS, and C.D.S.. All podcast content including episodes, graphics, and podcast descriptions are uploaded and provided directly by Esther C Kane CAPS, C.D.S., Esther C Kane CAPS, and C.D.S. or their podcast platform partner. If you believe someone is using your copyrighted work without your permission, you can follow the process outlined here https://player.fm/legal.

Summary of article on NY Post

A new study from Johns Hopkins Medicine suggests a link between the widely used thyroid medication levothyroxine (e.g., Synthroid) and increased bone loss in older adults, even those with normal thyroid function. The study, involving 445 participants, found that levothyroxine users experienced greater bone mass and density loss over six years compared to non-users. This raises concerns, especially given that a substantial portion of prescriptions may be issued unnecessarily to older adults. The researchers advise those taking levothyroxine to discuss potential risks, such as bone loss and osteoporosis, with their doctors. While levothyroxine treats hypothyroidism, the study indicates potential adverse effects that should be considered in relation to the benefits. The findings will be presented at the Radiological Society of North America's annual meeting.

  continue reading

30 episodes

Artwork
iconShare
 
Manage episode 452244769 series 3609475
Content provided by Esther C Kane CAPS, C.D.S., Esther C Kane CAPS, and C.D.S.. All podcast content including episodes, graphics, and podcast descriptions are uploaded and provided directly by Esther C Kane CAPS, C.D.S., Esther C Kane CAPS, and C.D.S. or their podcast platform partner. If you believe someone is using your copyrighted work without your permission, you can follow the process outlined here https://player.fm/legal.

Summary of article on NY Post

A new study from Johns Hopkins Medicine suggests a link between the widely used thyroid medication levothyroxine (e.g., Synthroid) and increased bone loss in older adults, even those with normal thyroid function. The study, involving 445 participants, found that levothyroxine users experienced greater bone mass and density loss over six years compared to non-users. This raises concerns, especially given that a substantial portion of prescriptions may be issued unnecessarily to older adults. The researchers advise those taking levothyroxine to discuss potential risks, such as bone loss and osteoporosis, with their doctors. While levothyroxine treats hypothyroidism, the study indicates potential adverse effects that should be considered in relation to the benefits. The findings will be presented at the Radiological Society of North America's annual meeting.

  continue reading

30 episodes

All episodes

×
 
Loading …

Welcome to Player FM!

Player FM is scanning the web for high-quality podcasts for you to enjoy right now. It's the best podcast app and works on Android, iPhone, and the web. Signup to sync subscriptions across devices.

 

Quick Reference Guide

Listen to this show while you explore
Play